Systemic steroid reduces long-term hearing loss in experimental pneumococcal meningitis

Laryngoscope

Volumn 120, Issue 9, 2010, Pages 1872-1879

  Worsøe, Lise ^a   Brandt, Christian Thomas ^b,c,d   Lund, Søren Peter ^e   Østergaard, Christian ^a,b   Thomsen, Jens ^a,d   Cayé Thomasen, Per ^a,d  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

Auditory brain stem response; Betamethasone; Cochlear pathology; Distortion product oto acoustic emission; Experimental meningitis; Hearing loss

Indexed keywords

BETAMETHASONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COCHLEA; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; HEARING LOSS; HISTOPATHOLOGY; MALE; NONHUMAN; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; RAT; SPIRAL GANGLION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BETAMETHASONE; COCHLEA; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; HEARING LOSS, SENSORINEURAL; INJECTIONS, INTRAMUSCULAR; MALE; MENINGITIS, PNEUMOCOCCAL; NEURONS; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RATS; RATS, WISTAR; SPIRAL GANGLION;

EID: 77956575935     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1002/lary.21007     Document Type: Article

References (19)

1. Weisfelt M, Hoogman M, van de Beek D, de Gans J, Dreschler WA, Schmand BA. Dexamethasone and longterm outcome in adults with bacterial meningitis. Ann Neurol 2006;60:456-468. (Pubitemid 44684982)
2. CayÉ -Thomasen P, Worsøe L, Brandt CT, Miyazaki H, Østergaard C, Frimodt-Møller N, Thomsen J. Routes, dynamics and correlates of cochlear inflammation in terminal and recovering experimental meningitis. Laryngoscope 2009;119:1560-1570.
3. Klein M, Koedel U, Pfister HW, Kastenbauer S. Morphological correlates of acute and permanent hearing loss during experimental pneumococcal meningitis. Brain Pathol 2003;13:123-132. (Pubitemid 36460813)
4. Rarey KE, Curtis LM. Receptors for glucocorticoids in the human inner ear. Otolaryngol Head Neck Surg 1996;115:38-41. (Pubitemid 26292360)
5. van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007;24:CD004405.
6. de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002;347: 1549-1556.
7. Molyneux EM, Walsh AL, Forsyth H, et al. Dexamethasone treatment in childhood bacterial meningitis in Malawi: a randomised controlled trial. Lancet 2002;360:211-218. (Pubitemid 34804649)
8. Rappaport JM, Bhatt SM, Burkard RF, Merchant SN, Nadol JB. Prevention of hearing loss in experimental pneumococcal meningitis by administration of dexamethasone and ketorolac. J Infect Dis 1999;179:264-268.
9. Kim HH, Addison J, Suh E, Trune DR, Richter CP. Otoprotective effects of dexamethasone in the management of pneumococcal meningitis: an animal study. Laryngoscope 2007;117:1209-1215.
10. Bhatt SM, Cabellos C, Nadol JB Jr, Halpin C, Lauretano A, Xu WZ, Tuomanen E. The impact of dexamethasone on hearing loss in experimental pneumococcal meningitis. Pediatr Infect Dis J 1995;14:93-96.
11. Coimbra RS, Loquet G, Leib SL. Limited efficacy of adjuvant therapy with dexamethasone in preventing hearing loss due to experimental pneumococcal meningitis in the infant rat. Pediatr Res 2007;62:291-294. (Pubitemid 47301477)
12. Yang GS, Song HT, Keithley EM, Harris JP. Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. Am J Otol 2000;21:499-504.
13. Kastenbauer S, Klein M, Koedel U, Pfister HW. Reactive nitrogen species contribute to blood-labyrinth barrier disruption in suppurative labyrinthitis complicating experimental pneumococcal meningitis in the rat. Brain Res 2001;904:208-217.
14. Brandt C, Lundgren JD, Lund SP, et al. Pre-treatment with G-CSF protects from fatal outcome and brain damage in Streptococcus pneumoniae meningitis in rats. Immun Infect 2004;72:4647-4653.
15. Rasmussen AN, Osterhammel PA, Lund SP, Kristiansen GB, Andersen S. A system for measuring distortion product otoacoustic emissions at ultra-sonic frequencies in rodents. Int J Audiol 2005;44:237-243. (Pubitemid 40896708)
16. Brandt CT, Cayé-Thomasen P, Lund SP, et al. Hearing loss and cochlear damage in experimental pneumococcal meningitis, with special reference to the role of neutrophil granulocytes. Neurobiol Dis 2006;23:300-311. (Pubitemid 44080841)
17. Mustafa MM, Ramilo O, Sáez-Llorens X, Olsen KD, Magness RR, McCracken GH Jr. Cerebrospinal fluid prostaglandins, interleukin 1 beta, and tumor necrosis factor in bacterial meningitis. Clinical and laboratory correlations in placebo-treated and dexamethasone-treated patients. Am J Dis Child 1990;144:883-887. (Pubitemid 20232954)
18. Matsumura M, Kakishita H, Suzuki M, Banba N, Hattori Y. Dexamethasone suppresses iNOS gene expression by inhibiting NF-kappaB in vascular smooth muscle cells. Life Sci 2001;69:1067-1077. (Pubitemid 32701917)
19. Mogensen TH, Berg RS, Paludan SR, Østergaard L. Mechanisms of dexamethasone-mediated inhibition of Toll-like receptor signaling induced by Neisseria meningitidis and Streptococcus pneumoniae. Infect Immun 2008;76: 189-197.